News

• The OCEANIC-AF (atrial fibrillation) study with asundexian is part of the Phase III OCEANIC clinical trial program enrolling more than 27,000 patients in over 40 countries • Asundexian is being evaluated as a potential improved treatment...

Momentum Continues as Depth of Clinical Experience Expands Worldwide

The longest-running and leading event for electrophysiologists heads to New Orleans to share agenda-setting science and innovation.

Acutus Medical, Inc. is pleased to announce its participation in the upcoming Heart Rhythm Society (HRS) Annual Scientific Sessions in New Orleans, LA, from May 19-21, 2023.

-Anticoagulant Bleeding Burden Adherence Confidence Assessment Scale [ABBA-CAS] Created to Better Address an Important Treatment Gap in the Management of Atrial Fibrillation (AF) and Bring Patient Issues to the Forefront -Developed with...

Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP™ Platform.

The company will show the latest proactive esophageal cooling technology at Booth 521 and host an evening meet-and-greet.

Cardiac Electrophysiology Key Opinions Leaders to include Paul Dorian, MD, and Jonathan Piccini, MD

LAGUNA HILLS, Calif., May 3, 2023 /-- Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), announced the completion of enrollment in its...

KardiaMobile Card Recognized for its Contributions to Digital Health MOUNTAIN VIEW, Calif., May 3, 2023/--AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced...